Kevin R. Thornal's Insider Trades & SAST Disclosures
Kevin R. Thornal's most recent trade in Nevro Corp was a trade of 27,029 Common Stock done at an average price of $5.8 . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin R. Thornal.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nevro Corp | Kevin R. Thornal | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 07 Mar 2025 | 27,029 | 216,133 (0%) | 0% | 5.8 | 155,957 | Common Stock |
| Nevro Corp | Kevin R. Thornal | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.16 per share. | 24 Jan 2025 | 6,685 | 243,162 (0%) | 0% | 5.2 | 34,495 | Common Stock |
| Nevro Corp | Kevin R. Thornal | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. | 24 Oct 2024 | 6,063 | 249,847 (0%) | 0% | 4.9 | 29,406 | Common Stock |
| Nevro Corp | Kevin R. Thornal | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 24 Jul 2024 | 6,061 | 255,910 (0%) | 0% | 9.7 | 59,034 | Common Stock |
| Nevro Corp | Kevin R. Thornal | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.51 per share. | 24 Apr 2024 | 24,233 | 261,971 (0%) | 0% | 12.5 | 303,155 | Common Stock |
| Nevro Corp | Kevin R. Thornal | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 150,581 | 286,204 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kevin R. Thornal | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 135,623 | 135,623 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 12,490 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Sale of securities on an exchange or to another person at price $ 75.30 per share. | 15 Nov 2022 | 12,490 | 62,368 (0%) | 0% | 75.3 | 940,509 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. | 15 Nov 2022 | 12,490 | 74,858 (0%) | 0% | 40.9 | 510,217 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Sale of securities on an exchange or to another person at price $ 75.37 per share. | 15 Nov 2022 | 6,628 | 62,368 (0%) | 0% | 75.4 | 499,552 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. | 09 Nov 2022 | 8,780 | 68,996 (0%) | 0% | 75.9 | 666,665 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Nov 2022 | 591 | 77,776 (0%) | 0% | 72.1 | 42,617 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 19,327 | 19,327 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 6,724 | 79,076 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Group Pres, Global Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. | 07 Nov 2022 | 709 | 78,367 (0%) | 0% | 73.7 | 52,260 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 12,277 | 72,352 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. | 11 Nov 2021 | 6,833 | 60,075 (0%) | 0% | 73.5 | 502,499 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. | 11 Nov 2021 | 632 | 66,908 (0%) | 0% | 72.6 | 45,890 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 20,803 | 20,803 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 6,150 | 68,130 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. | 08 Nov 2021 | 590 | 67,540 (0%) | 0% | 71.3 | 42,043 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 28,764 | 61,980 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2020 | 9,236 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. | 10 Dec 2020 | 9,236 | 42,452 (0%) | 0% | 37.6 | 347,643 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Sale of securities on an exchange or to another person at price $ 73.99 per share. | 10 Dec 2020 | 9,236 | 33,216 (0%) | 0% | 74.0 | 683,409 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 10 Dec 2020 | 7,633 | 33,216 (0%) | 0% | 74.0 | 564,804 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2020 | 7,633 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. | 10 Dec 2020 | 7,633 | 40,849 (0%) | 0% | 40.0 | 305,015 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. | 01 Dec 2020 | 5,450 | 33,216 (0%) | 0% | 69.6 | 379,484 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. | 12 Nov 2020 | 598 | 38,666 (0%) | 0% | 70.2 | 41,980 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 17,512 | 17,512 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 5,120 | 39,896 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. | 09 Nov 2020 | 632 | 39,264 (0%) | 0% | 69.8 | 44,139 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 17,750 | 34,776 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Sale of securities on an exchange or to another person at price $ 51.51 per share. | 15 May 2020 | 13,888 | 17,026 (0%) | 0% | 51.5 | 715,426 | Common Stock |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 13,888 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Kevin R. Thornal | Div. President, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.01 per share. | 15 May 2020 | 13,888 | 30,914 (0%) | 0% | 26.0 | 361,227 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges